Osborne Clarke | United Kingdom | 15 Dec 2022
The Court of Appeal has upheld the decision of the High Court to reject Teva's application for Arrow declaratory relief for importing and selling…
Bird & Bird LLP | Belgium, European Union, Netherlands | 9 Dec 2022
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with the original trade mark of the reference…
Venable LLP | USA | 5 Dec 2022
🕑 1 minute Novartis Pharmaceuticals Corporation recently secured a victory on a motion to dismiss certain defendants' counterclaims in patent litigation concerning Novartis's Entresto drug product. Judge Richard G Andrews, of the District Court for the District of Delaware, agreed with Novartis that a defendant who files a section viii statement does not face an article III controversy of......
McDermott Will & Emery | USA | 6 Oct 2022
In a rare action by the Supreme Court of the United States, Chief Justice Roberts granted Novartis’s emergency request for a stay of a mandate from…
De Berti Jacchia Franchini Forlani Studio Legale | European Union | 21 Jul 2022
In data 7 luglio 2022, la Corte di Giustizia dell’Unione Europea si è Pronunciata nella Causa C-261/21, F. Hoffmann-La Roche Ltd e a. Contro Autorità…
Kilpatrick Townsend & Stockton LLP | USA | 26 Jan 2022
The specification shall contain a written description of the invention. To meet the written description requirement, the applicant must convey with…
Lexology PRO | USA | 14 Apr 2021
A senior SEC enforcement official said it’s often a challenge for government lawyers to determine whether to impose a compliance monitor on a company.
Lexology Learn videos PRO
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
Rafael Ferri, legal director at Novartis (Brazil), looks back at his experiments with gamification to boost compliance-business engagement while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology Learn videos PRO
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices to boost compliance-business engagement that he used while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology Learn videos PRO
Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021
Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices he used to boost compliance-business engagement during the COVID-19 pandemic in his role as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.